中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Biosafety study and mechanism comparison on two types of silica with different nanostructures

文献类型:期刊论文

作者Zhang, Yang1; Chen, Xianhui1; Zhao, Bo1; Wu, Hounan2; Yuan, Lan2; Zhang, Hua1; Dai, Wenbing1; He, Bing1; Xing, Gengmei3; Zhang, Qiang1,4
刊名Toxicology research
出版日期2017-07-01
卷号6期号:4页码:487-498
ISSN号2045-452X
DOI10.1039/c7tx00076f
通讯作者Wang, xueqing(wangxq@bjmu.edu.cn)
英文摘要Silica is frequently used in oral drug delivery; however, its biosafety, particularly concerned with its nanostructure, has not been comprehensively studied yet. here, the in vitro and in vivo biosafety of two types of silica (a200, nano-sized or micron-sized agglomerates; s350, micro-sized particles with nanopores) were compared and the possible reasons for the differences were explored. the results indicated that both a200 and s350 could inhibit the growth of caco-2 cells by inducing apoptosis and changing the cell cycle progression. a200 showed a stronger influence than s350 in most of the in vitro experiments. in the in vivo study in km mice, both a200 and s350 could change the blood constituents under the tested conditions; a200 also increased the levels of inflammatory factors in plasma and the numbers of cd4+ lymphocyte subsets. no obvious organic damage was observed in either the a200-treated or s350-treated groups. the transport study showed that neither a200 nor s350 were readily transported across the intestinal epithelial barrier in vitro and in vivo, but a200 could transport across the lymphaticassociated epithelium and accumulate in the peyer's patches, which might explain the a200-induced immune response. the increased transport of a200 might relate to its particle size, dispersion state and specific surface area. in conclusion, these results demonstrated that a200 and s350 exhibited diverse biosafety aspects, which correlated with their different nanostructures. we believe this study will provide some scientific information about the biosafety of a200 and s350 for their applications in oral drug delivery systems.
WOS关键词IN-VIVO BIODISTRIBUTION ; OXIDATIVE STRESS ; VITRO TOXICITY ; PARTICLE-SIZE ; NANOPARTICLES ; CELLS ; DELIVERY ; CYTOTOXICITY ; ASSAY ; PHARMACOKINETICS
WOS研究方向Toxicology
WOS类目Toxicology
语种英语
WOS记录号WOS:000404873500011
出版者ROYAL SOC CHEMISTRY
URI标识http://www.irgrid.ac.cn/handle/1471x/2177286
专题高能物理研究所
通讯作者Wang, Xueqing
作者单位1.Peking Univ, Sch Pharmaceut Sci, Beijing Key Lab Mol Pharmaceut & New Drug Deliver, Beijing 100191, Peoples R China
2.Peking Univ, Med & Hlth Analyt Ctr, Beijing 100191, Peoples R China
3.Chinese Acad Sci, Inst High Energy Phys, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing 100049, Peoples R China
4.Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Yang,Chen, Xianhui,Zhao, Bo,et al. Biosafety study and mechanism comparison on two types of silica with different nanostructures[J]. Toxicology research,2017,6(4):487-498.
APA Zhang, Yang.,Chen, Xianhui.,Zhao, Bo.,Wu, Hounan.,Yuan, Lan.,...&Wang, Xueqing.(2017).Biosafety study and mechanism comparison on two types of silica with different nanostructures.Toxicology research,6(4),487-498.
MLA Zhang, Yang,et al."Biosafety study and mechanism comparison on two types of silica with different nanostructures".Toxicology research 6.4(2017):487-498.

入库方式: iSwitch采集

来源:高能物理研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。